Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2002-10-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1164/RCCM.2203011PMID 12359659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation.

  2001cited by this paper
• Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

  2001cited by this paper
• Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

  2001cited by this paper
• Evaluation of Random Amplified Polymorphic DNA Typing of Pseudomonas aeruginosa

  2000cited by this paper
• Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis.

  2000cited by this paper
• Identification and Population Structure ofBurkholderia stabilis sp. nov. (formerly Burkholderia cepacia Genomovar IV)

  2000cited by this paper
• Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

  2000cited by this paper
• BURKHOLDERIA CEPACIA: Management Issues and New Insights

  1998cited by this paper
• Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.

  1997cited by this paper
• Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis

  1997cited by this paper
• Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

  1997cited by this paper
• Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis

  1997cited by this paper
• Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic

  1996cited by this paper
• Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

  1996cited by this paper
• Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

  1996cited by this paper
• Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections

  1996cited by this paper
• Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis

  1996cited by this paper
• The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain

  1995cited by this paper
• Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

  1995cited by this paper
• A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. The International Pseudomonas aeruginosa Typing Study Group.

  1994cited by this paper
• Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis

  1994cited by this paper
• Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis.

  1993cited by this paper
• Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells.

  1993cited by this paper
• Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients

  1991cited by this paper
• Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis

  1990cited by this paper
• Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis.

  1987cited by this paper
• Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients

  1986cited by this paper
• An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.

  1986cited by this paper
• Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains

  1983cited by this paper
• Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp.

  1982cited by this paper
• Does pseudomonas cross-infection occur between cystic-fibrosis patients.

  1982cited by this paper

• Antibacterial and antibiofilm effect of Zinc Oxide nanoparticles on P. aeruginosa variants isolated from young patients with cystic fibrosis.

  2024cites this paper
• Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment

  2023cites this paper
• Antibacterial Activity of a Natural Clay Mineral against Burkholderia cepacia Complex and Other Bacterial Pathogens Isolated from People with Cystic Fibrosis

  2023cites this paper
• Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway Infections.

  2022cites this paper
• Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis

  2022cites this paper
• Minimising the risk of cross infection between siblings with cystic fibrosis (CF) within the home: Successful domestic steam disinfection of CF bacterial and foodborne pathogens on common household cutlery and crockery utensils.

  2021cites this paper
• Drug discovery through the isolation of natural products from Burkholderia

  2021cites this paper
• Evolution of Antibiotic Tolerance Shapes Resistance Development in Chronic Pseudomonas aeruginosa Infections

  2021cites this paper
• Epidemiology of Antibiotic Resistance Pattern of Pseudomonas Aeruginosa in Cystic Fibrosis Patients in Iran: A Systematic Review and Meta-Analysis

  2021cites this paper
• Ag/F Tio2 Nanoparticles activity against algD and plcH Genes of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis in Al Muthanna City

  2020cites this paper
• Evolution of Antibiotic Tolerance Shapes Resistance Development in Chronic Pseudomonas aeruginosa Infections

  2020cites this paper
• Pseudomonas aeruginosa strain sharing in early infection among children with cystic fibrosis.

  2020cites this paper
• Antibiogram of ESBL and MBL producing Pseudomonas aeruginosa among the population of Hazara division, KPK, Pakistan.

  2020cites this paper
• The Pseudomonas aeruginosa Population among Cystic Fibrosis Patients in Quebec, Canada: a Disease Hot Spot without Known Epidemic Isolates

  2019cites this paper
• Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm.

  2019cites this paper
• Is the Potable Water System an Advantageous Preinfection Niche for Bacteria Colonizing the Cystic Fibrosis Lung?

  2019cites this paper
• Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis

  2019cites this paper
• Assessment of Pseudomonas aeruginosa epidemiology and the wider microbial diversity within the bronchiectatic lung

  2018cites this paper
• Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis

  2018cites this paper
• Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population

  2018cites this paper
• Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.

  2018cites this paper
• Chapter 3 The Cystic Fibrosis Airway Microbiome and Pathogens

  2018cites this paper
• Transcriptional Responses of Pseudomonas aeruginosa to Potable Water and Freshwater

  2018cites this paper
• Life in the cystic fibrosis upper respiratory tract influences competitive ability of the opportunistic pathogen Pseudomonas aeruginosa

  2018cites this paper
• Structure‐Function Relationships of Rhamnolipid and Exopolysacharide Biosurfactants of Pseudomonas aeruginosa as Therapeutic Targets in Cystic Fibrosis Lung Infections

  2017cites this paper
• Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs

  2017influential citation
• The Cystic Fibrosis Airway Microbiome and Pathogens

  2017cites this paper
• Comparative genomics of Pseudomonas aeruginosa populations

  2017cites this paper
• Dissecting the Multiple Roles of PqsE in Pseudomonas aeruginosa Virulence by Discovery of Small Tool Compounds.

  2016cites this paper
• Application of fragment-based methods for the development of Pseudomonas aeruginosa anti-virulence compounds

  2016cites this paper
• Long-term clinical outcomes of ‘Prairie Epidemic Strain’ Pseudomonas aeruginosa infection in adults with cystic fibrosis

  2016cites this paper
• Analysis and Characterization of Staphylococcus aureus Small Colony Variants Isolated From Cystic Fibrosis Patients in Austria

  2016cites this paper
• Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy

  2016cites this paper
• Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.

  2016cites this paper
• Low‐level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients

  2015cites this paper
• Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis

  2015cites this paper
• Pseudomonas aeruginosa - Pathogenesis and Pathogenic Mechanisms

  2015cites this paper
• The Function and Regulation of Macrophage Matrix Metalloproteinase 10 (MMP-10) in Lung Injury and Fibrosis

  2015cites this paper
• Prevalence and Clonal Dissemination of Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa in Kermanshah

  2015cites this paper
• Impact of pseudomonas aeruginosa Liverpool epidemic strain (LES) on cystic fibrosis patients

  2015cites this paper
• Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis.

  2015cites this paper
• Profile of cystic fibrosis in two reference centers in southern Brazil.

  2015cites this paper
• Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients

  2014cites this paper
• Steam-treatment-based soil remediation promotes heat-tolerant, potentially pathogenic microbiota

  2014cites this paper
• Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

  2014cites this paper
• Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis.

  2014cites this paper
• Twenty-Five-Year Outbreak of Pseudomonas aeruginosa Infecting Individuals with Cystic Fibrosis: Identification of the Prairie Epidemic Strain

  2014cites this paper
• Practice of Epidemiology Differential Geographical Risk of Initial Pseudomonas aeruginosa Acquisition in Young US Children With Cystic Fibrosis

  2014cites this paper
• Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting

  2014cites this paper
• Role of Burkholderia cenocepacia afcE and afcF genes in determining lipid-metabolism-associated phenotypes.

  2013cites this paper
• Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.

  2013cites this paper
• Environmental risk factors for the initial acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis

  2013cites this paper
• Metabolite profiling to characterize disease-related bacteria: gluconate excretion by Pseudomonas aeruginosa mutants and clinical isolates from cystic fibrosis patients

  2013cites this paper
• Halting the spread of epidemic pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study

  2013cites this paper
• prospective cohort study in an adult cystic fibrosis centre: a pseudomonas aeruginosa Halting the spread of epidemic

  2013cites this paper
• Typing of Pseudomonas aeruginosa strains isolated from Greek water samples by three typing methods: serotyping, Random Amplified Polymorphic DNA (RAPD) and Pulsed Field Gel Electrophoresis (PFGE).

  2013cites this paper
• Metabolite Profiling to Characterize Disease-related Bacteria

  2013cites this paper
• pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study

  2013cites this paper
• Perceptions of hospital admission in patients with cystic fibrosis

  2013cites this paper
• Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral Children Medical Hospital in Tehran, Iran

  2013cites this paper
• Microsoft Word-gluconate JBC revised final.docx

  2013cites this paper
• Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections

  2012cites this paper
• Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern?

  2012cites this paper
• Molecular epidemiology ofPseudomonas aeruginosa in cystic fibrosis patients from Southeast Austria

  2012cites this paper
• Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis

  2012cites this paper
• Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.

  2012influential citation
• Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres

  2012cites this paper
• Moraxella catarrhalis Outer Membrane Vesicles Carry β-Lactamase and Promote Survival of Streptococcus pneumoniae and Haemophilus influenzae by Inactivating Amoxicillin

  2011cites this paper
• Moraxella catarrhalis outer membrane vesicles carry beta-lactamase

  2011cites this paper
• Italian national survey on molecular epidemiology of Pseudomonas aeruginosa from pulmonary infection of Cystic Fibrosis patients

  2011cites this paper
• pErFil microbiológico na FibrosE cística

  2011cites this paper
• Molecular Epidemiology of a Pseudomonas aeruginosa Hospital Outbreak Driven by a Contaminated Disinfectant-Soap Dispenser

  2011cites this paper
• Bacteriologia da Fibrose Cística

  2011cites this paper
• Épidémiologie de Pseudomonas aeruginosa chez les patients mucoviscidosiques

  2011cites this paper
• Capillary Electrophoresis of Bacterial (Lipo)Polysaccharides

  2011cites this paper
• Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.

  2011cites this paper
• Differential Habitat Use and Niche Partitioning by Pseudomonas Species in Human Homes

  2011cites this paper
• The molecular basis for preservative resistance in Burkholderia cepacia complex bacteria

  2011cites this paper
• Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

  2011cites this paper
• Pseudomonas aeruginosa Infection in Cystic Fibrosis: A Paradigm of Chronic Infection

  2011influential citation
• The Changing Microbial Epidemiology in Cystic Fibrosis

  2010cites this paper
• Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.

  2010cites this paper
• PSEUDOMONAS AERUGINOSA ISOLATES IN CYSTIC FIBROSIS SPUTUM Running title : Molecular typing of P . aeruginosa in CF

  2010cites this paper
• Challenging and emerging pathogens in cystic fibrosis.

  2010cites this paper
• Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: Assessment of clinic exposures and microbial genotypes

  2010cites this paper
• Evaluation of the efficacy of real-time polymerase chain reaction for the routine early detection of Pseudomonas aeruginosa in cystic fibrosis sputum and throat swab specimens.

  2010cites this paper
• Comparison of Three Molecular Techniques for Typing Pseudomonas aeruginosa Isolates in Sputum Samples from Patients with Cystic Fibrosis

  2010cites this paper
• Effects of a short‐term rehabilitation program on airway inflammation in children with cystic fibrosis

  2010cites this paper
• Impact of Pseudomonas aeruginosa Genomic Instability on the Application of Typing Methods for Chronic Cystic Fibrosis Infections

  2010cites this paper
• PSEUDOMONAS AERUGINOSA ISOLATES IN CYSTIC FIBROSIS SPUTUM

  2010cites this paper
• Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.

  2010cites this paper
• Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis

  2010cites this paper
• Activation of the Pseudomonas aeruginosa AlgU Regulon through mucA Mutation Inhibits Cyclic AMP/Vfr Signaling

  2010cites this paper
• Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.

  2010cites this paper
• Towards gene therapy for cystic fibrosis airway disease: development of single-dose lentiviral gene transfer for lifetime airway expression.

  2010cites this paper
• The Clinical Utility of Molecular Typing of Multiply-resistant Pseudomonas aeruginosa in Children with Cystic Fibrosis

  2010cites this paper
• Investigation into the introduction of clonal strains of Pseudomonas aeruginosa to the cystic fibrosis population by consumption of raw salad vegetables

  2010cites this paper
• Antibacterial Efficacy of Phages against Pseudomonas aeruginosa Infections in Mice and Drosophila melanogaster

  2009cites this paper
• Tratamiento antimicrobiano frente a la colonización pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis quística

  2009cites this paper
• Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.

  2009cites this paper